On Wallon Biotech Day organised at the Shanghai World Fair, in the Belgian Pavilion, Delphi Genetics announced its decision today to invest €3.5 million in a building that will be entirely dedicated to its activity. This 1500m² building will house the company’s Research & Development Department, its service activities and the manufacturing of its products.  
Since July 2006, Delphi Genetics has been renting an area of 450 square metres in Igretec’s bridging building in the Charleroi Aeropole Business Park near the Institute of Biology and Molecular Medicine (IBMM) of the University of Brussels (ULB). The new building, the inauguration of which is envisaged for 2012, will be located in the ULB’s Biopark, which already contains several Biotech companies.

Dr Cédric Szpirer, Chief Executive Officer of Delphi Genetics and one of its founders, explained:

“Delphi Genetics’ business is growing: we have more and more contacts with major

companies in the biopharmacy and biotechnology fields. These contacts lead to new licensing

agreements or partnerships and result in increased activity in terms of services and

production alike. We also have several research projects underway. We therefore need more

space to achieve our objectives. The new building will enable us to accommodate up to 45

people and an extension will be possible should it prove to be necessary.”

For more information, please, contact us or download the pdf file.